Researchers have created a highly detailed cellular map of Alzheimer’s disease progression, revealing new insights into the ...

It is estimated that less than one in ten people with dementia are eligible for treatment with Lecanemab or Leqembi, the ...

Dementia describes symptoms like memory loss in multiple diseases, and Alzheimer’s is the most common form. Here are the key ...

Researchers have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression. The proteins were gathered from cerebrospinal ...

Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted ...

A once-a-day pill that targets the production of the stress hormone cortisol in the brain has the potential to be the “holy ...

Obstructive sleep apnea has been linked to an increased risk of dementia in a new study—and the association was particularly ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

For so long, we had a drought when it came to treatment options for Alzheimer's, until the last few years when we've seen two ...